Submitted by Anonymous (not verified) on 22 August 2023 - 10:34
Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Multiple Sclerosis, Date of authorisation: 26/08/2013, Revision: 26, Status: Authorised
Source: